偶然分枝杆菌对阿莫西林或头孢噻吩与克拉维酸联合用药的体外敏感性。
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.
作者信息
Cynamon M H, Palmer G S
出版信息
Antimicrob Agents Chemother. 1983 Jun;23(6):935-7. doi: 10.1128/AAC.23.6.935.
Abstract
The comparative in vitro activity of cefoxitin, cephalothin, amoxicillin, and clavulanic acid in combination with the latter two agents against 13 isolates of Mycobacterium fortuitum was evaluated by agar dilution susceptibility testing. Amoxicillin was more active than cephalothin but less active than cefoxitin against the strains tested. Clavulanic acid in combination with these beta-lactams usually improved the activity by one or two dilutions compared with the beta-lactams alone.
摘要
通过琼脂稀释药敏试验评估了头孢西丁、头孢噻吩、阿莫西林以及克拉维酸（与后两种药物联合使用）对13株偶然分枝杆菌的体外比较活性。在受试菌株中，阿莫西林的活性高于头孢噻吩，但低于头孢西丁。与单独使用β-内酰胺类药物相比，克拉维酸与这些β-内酰胺类药物联合使用时，活性通常可提高1倍或2倍稀释度。
相似文献
1
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.偶然分枝杆菌对阿莫西林或头孢噻吩与克拉维酸联合用药的体外敏感性。
Antimicrob Agents Chemother. 1983 Jun;23(6):935-7. doi: 10.1128/AAC.23.6.935.
2
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.结核分枝杆菌、偶然分枝杆菌和龟分枝杆菌对阿莫西林克拉维酸钾的体外敏感性
Eur J Clin Microbiol. 1986 Aug;5(4):453-4. doi: 10.1007/BF02075706.
3
In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis.阿莫西林与克拉维酸联合对结核分枝杆菌的体外活性
Antimicrob Agents Chemother. 1983 Sep;24(3):429-31. doi: 10.1128/AAC.24.3.429.
4
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.偶然分枝杆菌偶然生物变种以及龟分枝杆菌两个亚群对亚胺培南、头孢美唑、头孢西丁和阿莫西林-克拉维酸的敏感性。
Antimicrob Agents Chemother. 1991 Apr;35(4):773-5. doi: 10.1128/AAC.35.4.773.
5
Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents.非结核分枝杆菌对单独使用阿莫西林-克拉维酸以及与抗分枝杆菌药物联合使用的敏感性。
Antimicrob Agents Chemother. 1995 Jul;39(7):1454-7. doi: 10.1128/AAC.39.7.1454.
6
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.结核分枝杆菌、非洲分枝杆菌、牛分枝杆菌、鸟分枝杆菌、偶然分枝杆菌和龟分枝杆菌对替卡西林联合克拉维酸的体外敏感性。
Antimicrob Agents Chemother. 1987 Jan;31(1):132-3. doi: 10.1128/AAC.31.1.132.
7
In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.偶然分枝杆菌对头孢西丁的体外敏感性
Antimicrob Agents Chemother. 1981 Jan;19(1):205-7. doi: 10.1128/AAC.19.1.205.
8
Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.巴西奴卡菌对β-内酰胺类药物的耐药性由β-内酰胺酶介导，在克拉维酸存在的情况下耐药性可逆转。
J Infect Dis. 1987 Dec;156(6):959-66. doi: 10.1093/infdis/156.6.959.
9
Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility.偶然分枝杆菌中β-内酰胺酶的特性，包括其在β-内酰胺耐药性中的作用及部分诱导性的证据
Am Rev Respir Dis. 1986 Dec;134(6):1276-82. doi: 10.1164/arrd.1986.134.5.1276.
引用本文的文献
1
Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents.非结核分枝杆菌对单独使用阿莫西林-克拉维酸以及与抗分枝杆菌药物联合使用的敏感性。
Antimicrob Agents Chemother. 1995 Jul;39(7):1454-7. doi: 10.1128/AAC.39.7.1454.
2
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.偶然分枝杆菌和龟分枝杆菌五个亚组的抗菌药敏性
Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807.
3
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.结核分枝杆菌、非洲分枝杆菌、牛分枝杆菌、鸟分枝杆菌、偶然分枝杆菌和龟分枝杆菌对替卡西林联合克拉维酸的体外敏感性。
Antimicrob Agents Chemother. 1987 Jan;31(1):132-3. doi: 10.1128/AAC.31.1.132.
4
Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316.偶然分枝杆菌D316产生的一种β-内酰胺酶的特性分析。
Biochem J. 1990 Nov 1;271(3):729-34. doi: 10.1042/bj2710729.
5
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.偶然分枝杆菌偶然生物变种以及龟分枝杆菌两个亚群对亚胺培南、头孢美唑、头孢西丁和阿莫西林-克拉维酸的敏感性。
Antimicrob Agents Chemother. 1991 Apr;35(4):773-5. doi: 10.1128/AAC.35.4.773.
6
Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae.细胞壁屏障与β-内酰胺酶活性的相互作用决定了龟分枝杆菌对β-内酰胺类抗生素的高抗性。
Antimicrob Agents Chemother. 1991 Sep;35(9):1937-9. doi: 10.1128/AAC.35.9.1937.
7
Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.偶然分枝杆菌的β-内酰胺酶：产生动力学及其与对β-内酰胺抗生素耐药性的关系
Antimicrob Agents Chemother. 1991 Sep;35(9):1760-4. doi: 10.1128/AAC.35.9.1760.
本文引用的文献
1
Properties of beta-lactamases produced by three species of mycobacteria.三种分枝杆菌产生的β-内酰胺酶的特性。
Biochem J. 1968 May;107(5):675-82. doi: 10.1042/bj1070675.
2
In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.偶然分枝杆菌对头孢西丁的体外敏感性
Antimicrob Agents Chemother. 1981 Jan;19(1):205-7. doi: 10.1128/AAC.19.1.205.
3
In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.替莫西林（BRL 17421）的体外活性，一种新型的β-内酰胺酶稳定青霉素。
Antimicrob Agents Chemother. 1982 Jul;22(1):157-61. doi: 10.1128/AAC.22.1.157.
4
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.偶然分枝杆菌对N-甲酰亚胺基硫霉素及几种头孢霉素的体外敏感性
Antimicrob Agents Chemother. 1982 Dec;22(6):1079-81. doi: 10.1128/AAC.22.6.1079.
5
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.一种使用显色头孢菌素底物检测β-内酰胺酶的新方法。
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8. doi: 10.1128/AAC.1.4.283.
6
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.一种利用蛋白质 - 染料结合原理对微克级蛋白质进行定量的快速灵敏方法。
Anal Biochem. 1976 May 7;72:248-54. doi: 10.1016/0003-2697(76)90527-3.
7
Description and classification of the newer cephalosporins and their relationships with the established compounds.新型头孢菌素的描述、分类及其与现有化合物的关系。
J Antimicrob Chemother. 1979 Nov;5(6):635-71. doi: 10.1093/jac/5.6.635.
Zotero 插件